Squarepoint
HAE icon

Squarepoint’s Haemonetics HAE Stock Holding History

Squarepoint’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,300
Closed -$892K – 4508
2025
Q3 		$892K Buy
+18,300
New +$1.13M ﹤0.01% 2783
2025
Q1 		– Sell
-12,200
Closed -$953K – 4922
2024
Q4 		$953K Buy
+12,200
New +$980K ﹤0.01% 3111

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Squarepoint's HAE Position: Q1 2026 in Review

Squarepoint opened a new position in Haemonetics (HAE) in Q1 2026: 29,281 shares worth $1.65M. The stake represents ﹤0.01% of the portfolio and ranks #2351 among its holdings. This is a return to the name: Squarepoint previously reported a position in HAE as recently as Q3 2025.

Squarepoint first reported a position in HAE in Q3 2017 and has held it in 21 quarters since. The position peaked at $14.7M in Q1 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Squarepoint held 29,281 shares of Haemonetics worth $1.65M as of Q1 2026.
  • Haemonetics was a new Squarepoint position in Q1 2026.
  • Haemonetics made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2351 holding.
  • Squarepoint first reported a position in Haemonetics in Q3 2017 and has held it in 21 quarters since.
  • Squarepoint's Haemonetics position peaked at $14.7M in Q1 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.